Echocardiographic and Clinical Correlates of Ejection Fraction Among 2000 Patients with Heart Failure in Western Saudi Arabia

Echocardiographic and Clinical Correlates of Ejection Fraction Among 2000 Patients with Heart Failure in Western Saudi Arabia

Ahmed Hussein Subki,1 Mohammed Ali Almalki,2 Nadeem Shafique Butt,3 Mohammed Saad Alsallum,4 Hatim Mashan Almutairi,5 Hazim Abdulkarim Khatib,6 Abdulrahman Mousa Alzahrani,6 Abdullah Salem Babaker,6 Firas Abdulrahman Addas,6 Abdullah Abdulfattah Mashat,7 Ammar Yasser Jad,6 Zohair Abdulwahab Zafar,6...

Full description

Bibliographic Details
Main Authors:	Subki AH, Almalki MA, Butt NS, Alsallum MS, Almutairi HM, Khatib HA, Alzahrani AM, Babaker AS, Addas FA, Mashat AA, Jad AY, Zafar ZA, Nogali BW, Alghamdi AA, Alghamdi NA, Dakhakhni MF, Asaad OT, Alghalayini KW
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-06-01
Series:	International Journal of General Medicine
Subjects:	echocardiography heart failure saudi arabia ejection fraction hfpef hfmref hfref.
Online Access:	https://www.dovepress.com/echocardiographic-and-clinical-correlates-of-ejection-fraction-among-2-peer-reviewed-article-IJGM

Similar Items

Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions
by: Alem MM
Published: (2021-02-01)

Highlights in heart failure
by: Daniela Tomasoni, et al.
Published: (2019-12-01)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
by: Verena Tscholl, et al.
Published: (2021-08-01)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
by: Teng Ma, et al.
Published: (2021-05-01)

Approach to the Treatment of Heart Failure With Preserved Ejection Fraction and Mid-Range Ejection Fraction
by: Ewa A Jankowska, et al.
Published: (2017-01-01)

Heart Failure: The Dilemma of the 40-50% Ejection Fraction Range
by: Michael Henein, et al.
Published: (2017-01-01)

Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
by: Andreas B. Gevaert, et al.
Published: (2021-08-01)

Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction
by: Ana Belen Mendez Fernandez, et al.
Published: (2020-10-01)

Heart rate at discharge in patients with acute decompensated heart failure is a predictor of mortality
by: Thomas Vollmert, et al.
Published: (2020-10-01)

A registry‐based algorithm to predict ejection fraction in patients with heart failure
by: Alicia Uijl, et al.
Published: (2020-10-01)

Heart failure in Finland: clinical characteristics, mortality, and healthcare resource use
by: Jenni Huusko, et al.
Published: (2019-08-01)

Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis
by: Diana Michels da Silva, et al.
Published: (2019-05-01)

Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)

Acute decompensated heart failure in a North Indian community hospital: Demographics, clinical characteristics, comorbidities and adherence to therapy
by: Sri Harsha Onteddu, et al.
Published: (2020-01-01)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
by: Christopher J. Charles, et al.
Published: (2020-10-01)

Real‐world clinical diagnostics of heart failure patients with reduced or preserved ejection fraction
by: Jenni Huusko, et al.
Published: (2020-06-01)

Independent predictors of developing pulmonary hypertension in heart failure with reduced versus preserved ejection fraction
by: Alaa Roushdy, et al.
Published: (2017-07-01)

Endothelial dysfunction and the risk of heart failure in a community‐based study: the Multi‐Ethnic Study of Atherosclerosis
by: Johan Ärnlöv, et al.
Published: (2020-12-01)

Heart failure in the last year: progress and perspective
by: Daniela Tomasoni, et al.
Published: (2020-12-01)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
by: Leonie Grossekettler, et al.
Published: (2020-05-01)

Circulating neuregulin1‐β in heart failure with preserved and reduced left ventricular ejection fraction
by: Camilla Hage, et al.
Published: (2020-04-01)

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
by: Chen Chi, et al.
Published: (2021-08-01)

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
by: Peter Jirak, et al.
Published: (2020-04-01)

PUFA Supplementation and Heart Failure: Effects on Fibrosis and Cardiac Remodeling
by: Francesca Oppedisano, et al.
Published: (2021-08-01)

Cardioprotection by SGLT2 Inhibitors—Does It All Come Down to Na<sup>+</sup>?
by: Maximilian Trum, et al.
Published: (2021-07-01)

The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study
by: Bianca Dahlen, et al.
Published: (2021-08-01)

Role of cardiopulmonary stress testing in heart failure management
by: Nandini Nair, et al.
Published: (2016-07-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction
by: Hiroyuki Naruse, et al.
Published: (2021-08-01)

Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
by: Anush Barkhudaryan, et al.
Published: (2021-03-01)

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

CMR Tissue Characterization in Patients with HFmrEF
by: Patrick Doeblin, et al.
Published: (2019-11-01)

Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
by: Abdallah Al‐Mohammad
Published: (2019-08-01)

Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China
by: Younan Yao, et al.
Published: (2020-12-01)

Acute pleiotropic effects of dapagliflozin in type 2 diabetic patients with heart failure with reduced ejection fraction: a crossover trial
by: Fahmida Ilyas, et al.
Published: (2021-10-01)

Impact of severe obesity on exercise performance in heart failure with preserved ejection fraction
by: Satyam Sarma, et al.
Published: (2020-11-01)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
by: Heng Zeng, et al.
Published: (2019-02-01)

Stellenwert von GDF-15 bei Patienten mit einer diastolischen Dysfunktion und Herzinsuffizienz mit erhaltener linksventrikulärer Ejektionsfraktion
by: Gabriel, Fabian
Published: (2014)

Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction
by: Gabrielle Fusco‐Allison, et al.
Published: (2021-10-01)

Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
by: Gregor Poglajen, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_flesvqcr94jkbmflltvhchf7ji